Literature DB >> 22166403

Huntington's disease: new aspects on phenotype and genotype.

Huifang Shang1, Adrian Danek, Bernhard Landwehrmeyer, Jean-Marc Burgunder.   

Abstract

Huntington's disease typically presents with involuntary movements, cognitive decline and behavioural abnormalities; however, new data show a greater spectrum and more complexity in the mode of presentation than previously appreciated. On one hand efforts are under way to better assess all aspects of the evolving phenotype over the course of the disease, on the other hand large cohorts have been prospectively followed-up and similar efforts are now being started in China. In this communication, we briefly review the most salient findings from the last couple of years. The recently established large cohorts allow the performance of accurate studies examining correlation of genetic polymorphisms with specific aspects of the phenotype thus allowing for some mechanistic insight into the causes of phenotypic variation. While Huntington's disease is the most frequent hereditary cause of chorea, other disorders with similar clinical phenotypes, including neuroacanthocytosis, are now better known, including a better understanding of the primary cause as well as the pathophysiology at the molecular level. Studies on the mechanisms of disease in these different disorders may shed light on the respective pathomechanisms and may open new approaches to a better understanding and additional treatment options for choreatiform neurodegenerative disorders.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22166403     DOI: 10.1016/S1353-8020(11)70034-7

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

Review 1.  A Glimpse of Molecular Biomarkers in Huntington's Disease.

Authors:  Silvia Martí-Martínez; Luis M Valor
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

2.  Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.

Authors:  Erin E Watkin; Nicolas Arbez; Elaine Waldron-Roby; Robert O'Meally; Tamara Ratovitski; Robert N Cole; Christopher A Ross
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

Review 3.  Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.

Authors:  Luis M Valor
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

4.  Transcriptional correlates of the pathological phenotype in a Huntington's disease mouse model.

Authors:  Andrea Gallardo-Orihuela; Irati Hervás-Corpión; Carmen Hierro-Bujalance; Daniel Sanchez-Sotano; Gema Jiménez-Gómez; Francisco Mora-López; Antonio Campos-Caro; Monica Garcia-Alloza; Luis M Valor
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.